Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 4/2018

01-12-2018 | NON-THEMATIC REVIEW

MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation

Published in: Cancer and Metastasis Reviews | Issue 4/2018

Login to get access

Abstract

Deciphering the paths to metastasis and identifying key molecules driving this process is one important issue for understanding and treatment of cancer. Such a key driver molecule is Metastasis Associated in Colon Cancer 1 (MACC1). A decade long research on this evolutionarily conserved molecule with features of a transcription factor as well as an adapter protein for versatile protein-protein interactions has shown that it has manifold properties driving tumors to their metastatic stage. MACC1 transcriptionally regulates genes involved in epithelial-mesenchymal transition (EMT), including those which are able to directly induce metastasis like c-MET, impacts tumor cell migration and invasion, and induces metastasis in solid cancers. MACC1 has proven as a valuable biomarker for prognosis of metastasis formation linked to patient survival and gives promise to also act as a predictive marker for individualized therapies in a broad variety of cancers. This review discusses the many features of MACC1 in the context of the hallmarks of cancer and the potential of this molecule as biomarker and novel therapeutic target for restriction and prevention of metastasis.
Literature
1.
Stein, U., & Schlag, P. M. (2007). Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 176, 61–80.PubMed
2.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. https://​doi.​org/​10.​3322/​caac.​21492.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Mudduluru, G., Ilm, K., Dahlmann, M., & Stein, U. (2017). MACC1, a novel player in solid cancer carcinogenesis. In Mechanisms of molecular carcinogenesis – volume 1 (pp. 11–38). Cham: Springer International Publishing.CrossRef
12.
13.
14.
Sun, D.-W., Zhang, Y.-Y., Qi, Y., Liu, G.-Q., Chen, Y.-G., Ma, J., et al. (2015). Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis. International Journal of Clinical and Experimental Medicine, 8, 4769–4777.PubMedPubMedCentral
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Li, H. F., Liu, Y. Q., Shen, Z. J., Gan, X. F., Han, J. J., Liu, Y. Y., et al. (2015). Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. Oncology Reports, 33(2), 651–660. https://​doi.​org/​10.​3892/​or.​2014.​3612.CrossRefPubMed
26.
27.
28.
29.
30.
Zhang, Q., Zhang, B., Sun, L., Yan, Q., Zhang, Y., Zhang, Z., et al. (2018). Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation. Acta Biochimica et Biophysica Sinica Shanghai, 50(8), 748–756. https://​doi.​org/​10.​1093/​abbs/​gmy074.CrossRef
31.
32.
33.
34.
35.
Kawamura, M., Saigusa, S., Toiyama, Y., Tanaka, K., Okugawa, Y., Hiro, J., et al. (2012). Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Research, 32(4), 1527–1531.PubMed
36.
37.
38.
39.
40.
Kokoszyńska, K., Kryński, J., Rychlewski, L., & Wyrwicz, L. S. (2009). Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochimica Polonica, 56, 317–323.CrossRef
41.
42.
43.
44.
45.
46.
47.
Tokarz, P., & Blasiak, J. (2012). The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochimica Polonica, 59, 467–474.CrossRef
48.
49.
50.
51.
52.
53.
54.
Hua, F.-F., Liu, S.-S., Zhu, L.-H., Wang, Y.-H., Liang, X., Ma, N., et al. (2017). MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway. European Review for Medical and Pharmacological Sciences, 21, 5342–5352.PubMed
55.
56.
57.
58.
59.
60.
61.
62.
Tokarz, P., Pawlowska, E., Bialkowska-Warzecha, J., & Blasiak, J. (2017). The significance of DNA methylation profile in metastasis-related genes for the progression of colorectal cancer. Cellular and Molecular Biology (Noisy-le-Grand, France), 63, 79–87.CrossRef
63.
64.
65.
66.
67.
Shirahata, A., Sakata, M., Kitamura, Y., Sakuraba, K., Yokomizo, K., Goto, T., et al. (2010). MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Research, 30(9), 3441–3444.PubMed
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
Zhang, K., Tian, F., Zhang, Y., Zhu, Q., Xue, N., Zhu, H., et al. (2014). MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biology, 35(3), 2537–2548. https://​doi.​org/​10.​1007/​s13277-013-1335-5.CrossRefPubMed
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
Qian, L. Q., Li, X. Q., Ye, P. H., Su, H. Y., Wang, G., Liu, Y., et al. (2017). Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. Oncology Letters, 14(4), 4897–4905. https://​doi.​org/​10.​3892/​ol.​2017.​6790.CrossRefPubMedPubMedCentral
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
Wang, L., Wu, Y., Lin, L., Liu, P., Huang, H., Liao, W., et al. (2013). Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. International Journal of Cancer, 133(6), 1419–1430. https://​doi.​org/​10.​1002/​ijc.​28140.CrossRefPubMed
114.
115.
116.
117.
118.
Zhang, X. K., Zhang, L. X., Jia, C. Y., Sun, H. M., Zou, Q. G., Wang, Z., et al. (2017). MACC1 overexpression induces cisplatin resistance in lung adenocarcinoma A549 cells by activating c-Met/Akt pathway. International Journal of Clinical and Experimental Medicine, 10(8), 11778–11786.
119.
Modiano, J. F., & Bellgrau, D. (2016). Fas ligand based immunotherapy: A potent and effective neoadjuvant with checkpoint inhibitor properties, or a systemically toxic promoter of tumor growth? Discovery Medicine, 21, 109–116.PubMed
120.
Jazirehi, A. R., Lim, A., & Dinh, T. (2016). PD-1 inhibition and treatment of advanced melanoma-role of pembrolizumab. American Journal of Cancer Research, 6(10), 2117–2128.PubMedPubMedCentral
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
Duan, J., Sun, L., Zhao, L., Liao, W. W., Liao, Y., Duan Jiangman, S. L., Liang, Z., Liao, W., Jing, L., Liao, Y., & Liao, W. (2014). Participation of metastasis-associated in colon cancer-1 gene on lipogenesis and chemoresistance of gastric cancer. Journal of Clinical Oncology, 32, e15026.CrossRef
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
Metadata
Title
MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation
Publication date
01-12-2018
Published in
Cancer and Metastasis Reviews / Issue 4/2018
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-018-9771-8

Other articles of this Issue 4/2018

Cancer and Metastasis Reviews 4/2018 Go to the issue

NON-THEMATIC REVIEW

Perspectives on the role of brain cellular players in cancer-associated brain metastasis: translational approach to understand molecular mechanism of tumor progression

OriginalPaper

Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review

ReviewPaper

From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma

OriginalPaper

Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment

EditorialNotes

Preface

OriginalPaper

Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits